American Oncology Network, Inc.
AONC
$6.01
$0.010.17%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 37.79% | 27.00% | 20.01% | 12.45% | 11.23% |
| Total Other Revenue | 15.15% | 13.97% | 11.94% | 17.64% | 14.72% |
| Total Revenue | 37.55% | 26.87% | 19.93% | 12.50% | 11.27% |
| Cost of Revenue | 74.87% | 30.77% | 24.79% | 17.42% | 13.51% |
| Gross Profit | 90.63% | -16.40% | -30.01% | -36.21% | -12.83% |
| SG&A Expenses | 65.10% | 35.88% | 28.30% | 17.18% | 15.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.89% | 31.16% | 25.06% | 17.40% | 13.70% |
| Operating Income | 10.20% | -665.39% | -429.04% | -323.65% | -302.62% |
| Income Before Tax | 31.46% | -266.23% | -- | -1,113.64% | -- |
| Income Tax Expenses | 550.52% | 737.78% | -- | -- | -- |
| Earnings from Continuing Operations | 25.26% | -277.06% | -- | -1,172.69% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.71% | 257.92% | -- | -- | -- |
| Net Income | 28.31% | -404.41% | -- | -314.32% | -- |
| EBIT | 10.20% | -665.39% | -429.04% | -323.65% | -302.62% |
| EBITDA | 41.12% | -320.40% | -267.59% | -220.79% | -160.84% |
| EPS Basic | -4.57% | -310.35% | -2,277.58% | -- | -- |
| Normalized Basic EPS | -52.07% | 50.39% | 1,050.16% | -- | -- |
| EPS Diluted | -23.36% | -355.23% | -2,488.97% | -- | -- |
| Normalized Diluted EPS | -66.22% | 25.73% | 967.53% | -- | -- |
| Average Basic Shares Outstanding | 107.44% | 96.98% | 145.23% | -- | -- |
| Average Diluted Shares Outstanding | 203.62% | 226.61% | 339.72% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.80% | -- | -- | -- |